8-K: Nuburu Secures $500,000 in Convertible Notes from Torcross Capital, Restructures Preferred Stock

Nuburu, Inc. has entered into agreements with Torcross Capital LLC to issue $500,000 in unsecured convertible notes, partially in exchange for preferred stock and partially for a new capital infusion.

Summary

• Nuburu, Inc. entered into two transactions with Torcross Capital LLC on June 25, 2025.
• A $400,000 face amount unsecured, convertible note was issued to Torcross Capital LLC in exchange for 40,000 shares of Nuburu's outstanding Series A Preferred Stock.
• A $100,000 face amount unsecured, convertible note was issued to Torcross Capital LLC in exchange for a $100,000 capital infusion.
• Both notes bear no interest for so long as they are not in default and have a maturity date of June 24, 2026.
• The conversion price for both notes is equal to 80% of the lowest Volume Weighted Average Price (VWAP) during the 5 days prior to the conversion date.
• Issuances of common stock upon conversion of these notes are limited to an amount equal to 19.9% of the outstanding common stock as of the date of execution, until stockholder approval is obtained.
• Torcross Capital LLC may not hold more than 9.9% of Nuburu's outstanding common stock at any time.
• The notes are subordinate to the currently outstanding Series A Preferred Stock solely with respect to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution, or winding up of the company's affairs.
• The securities were sold in a private placement to an accredited investor, exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended.

Sentiment

Score: 5

Explanation: The transaction addresses immediate capital needs and restructures preferred stock, which is positive for liquidity. However, the terms, particularly the discounted conversion price and potential for significant dilution, introduce future risks for common shareholders, balancing the overall sentiment to neutral.

Positives

• Secured a $100,000 capital infusion, providing additional liquidity.
• Reduced outstanding Series A Preferred Stock by 40,000 shares by converting it into a convertible note, potentially simplifying the capital structure.
• The convertible notes bear no interest unless in default, minimizing immediate cash interest payments.

Negatives

• The issuance of convertible notes, especially at 80% of the lowest VWAP, poses a significant risk of dilution for existing common stockholders upon conversion.
• The company is taking on new debt obligations, albeit convertible, which adds to its financial commitments.
• The need for a capital infusion and the exchange of preferred stock for convertible debt may indicate ongoing liquidity challenges or a need for balance sheet restructuring.
• Future stockholder approval is required for conversions exceeding 19.9% of outstanding common stock, introducing a potential hurdle for full conversion.

Risks

• Potential significant dilution for existing common stockholders if the convertible notes are converted, particularly due to the 80% of lowest VWAP conversion price.
• Risk of default on the notes, which would trigger interest accrual and other customary default provisions.
• Uncertainty regarding obtaining stockholder approval for common stock conversions exceeding 19.9% of outstanding common stock.
• The subordination of the new convertible notes to Series A Preferred Stock in liquidation or dissolution scenarios.

Future Outlook

The company anticipates needing stockholder approval for common stock conversions from the notes that would exceed 19.9% of its outstanding common stock, indicating a future corporate action.

Industry Context

This transaction represents a common strategy for companies, particularly those in growth or capital-intensive sectors, to raise capital and manage their balance sheets. The use of convertible notes allows for delayed equity dilution while securing immediate funding and restructuring existing obligations.

Comparison to Industry Standards

• The issuance of convertible notes at a discount to VWAP (80%) is a common feature in distressed or growth-stage financing, often seen when companies need capital quickly and are willing to offer favorable conversion terms to investors.
• The 19.9% conversion cap prior to stockholder approval is a standard practice to avoid triggering certain exchange rules or shareholder meeting requirements before a formal vote.

Corporate Governance

Stakeholder Impact

• Shareholders: Face potential significant dilution from the conversion of the notes, especially given the discounted VWAP conversion price. However, the capital infusion may support company operations.
• Creditors: New unsecured debt is introduced, which is subordinate to Series A Preferred Stock in certain liquidation scenarios.
• Company: Gains $100,000 in new capital and restructures a portion of its preferred stock, potentially improving its balance sheet and liquidity position in the short term.

Next Steps

• Obtain stockholder approval for common stock conversions exceeding 19.9% of outstanding common stock.
• Manage the convertible notes until their maturity on June 24, 2026.

Key Dates

Recommendation

Keywords

Nuburu, BURU, Convertible Note, Capital Raise, Private Placement, SEC Filing, 8-K, Torcross Capital, Series A Preferred Stock, Dilution, Debt Restructuring